This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an apparently unprecedented move, Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money. Most drug companies have venture funds, which they use both to make investments and to scout out potentially important scientific and technological trends. But it is unusual for a drug giant to co-manage a fund with an existing venture capital firm, or for a venture capital fund to source its capital from a
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do plan to promenade with the official mascots, catch up on our reading and hold a listening party with Mrs. Pharmalot, where the rotation will likely include this , this , this , this and this.
Sarah Gray, PharmD, GAICD, known as the Nutrition Pharmacist, joined Drug Topics to discuss her experience with patients looking to begin healthier lifestyles at the start of a new year.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The acceleration of artificial intelligence is arriving just in time for the biopharmaceutical industry. The global demand for innovative, effective treatments is growing faster than ever as the world’s largest drugmakers face intensifying regulatory, pricing, and political pressure. In this challenging environment, traditional industry processes must simply move faster.
Gabapentin is a prescription medication used to treat nerve pain and epilepsy. Although gabapentin is an anticonvulsant , its often used off-label to treat restless legs syndrome (RLS) and other nerve conditions or neuropathic pain. It can also treat postherpetic neuralgia, a type of pain that happens after having shingles. Brand names include Neurontin and Gralise.
Gabapentin is a prescription medication used to treat nerve pain and epilepsy. Although gabapentin is an anticonvulsant , its often used off-label to treat restless legs syndrome (RLS) and other nerve conditions or neuropathic pain. It can also treat postherpetic neuralgia, a type of pain that happens after having shingles. Brand names include Neurontin and Gralise.
Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM, discuss a recent study that examined how wearing a continuous glucose monitor impacts student pharmacists.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Ready for JPM? We’ll be on the ground and covering it in-depth next week. Please note: This newsletter will be dropping into your inbox in the afternoon instead of in the morning.
As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.
Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for its novel contractile agents. The round was co-led by Novo Holdings, Pureos Bioventures and Sound Bioventures. AnaCardios AC01 is a calcium sensitising inotrope, selective oral ghrelin receptor (GHSR1a) agonist in development to improve contractility in […] The post AnaCardio raises $19m in funding round for heart failure candidate appeared first on Phar
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
Ahead of next week’s J.P. Morgan Healthcare Conference, several PhRMA board members spoke with investors during a virtual conversation about what the new Congress and administration should focus on as they set their 2025 health care agenda.
CMS is recommending a 2.23% payment increase from the federal government to MA plans. Payers will likely be much happier at this year's advance notice than the prior year's rate cut.
NP Thyroid is a naturally sourced prescription thyroid hormone medication derived from porcine (pig) thyroid glands. NP Thyroid is used in the treatment of low thyroid hormone levels (hypothyroidism) of various causes. It contains two thyroid hormone components: liothyronine (T3) and levothyroxine (T4). Low thyroid hormone levels can result from many things, including an underactive thyroid gland, thyroid gland removal, or thyroid cancer.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Private equity firm New Mountain Capital plans to acquire Machinify and combine its with its previous merger of The Rawlings Group, Apixios Payment Integrity business and Varis to create a powerhouse in the payment integrity market. The combined entity will have revenue of more than $500 million.
The National Institute for Health and Care Excellence (NICE) has recommended Lynparza (olaparib) for adults with HER2-negative, locally advanced or metastatic breast cancer with germline BRCA1 or BRCA2 mutations after chemotherapy. NICEs final draft guidance on the poly-ADP ribose polymerase (PARP) inhibitor was based on positive results from the pivotal OlympiAD Phase III trial.
You may have missed this month. Massachusetts ordered UnitedHealth companies to pay $165 million for tricking customers to buy supplemental insurance, Scripps Health is no longer in market for Anthem Blue Cross members and Molina Healthcare is addressing depressive disorders with a new home health partnership.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
A group of UnitedHealth Group shareholders are pressuring the company to examine practices they say deny or limit patient access to care. | A group of UnitedHealth Group shareholders are pressuring the company to examine practices they say deny or limit patient access to care.
Drugstore chain Walgreens reported a loss of $265 million in its fiscal first quarter, which ended November 30, as it executes an ongoing turnaround strategy and continues to struggle with lower retail sales.
Invikafusp alfa (STAR0602; Marengo Therapeutics Inc) is being investigated as a treatment for advanced colorectal cancer with high tumor mutational burden.
The report includes four policy briefs on the top issues affecting kids in the area, including resiliency, vaccinations, the child welfare system and transition to adulthood. Cross-sector workgroups in each area met during a roundtable in November 2023.
Health tech company Innovaccer secured a $275 million series F funding round to invest in artificial intelligence with the goal to become a one stop shop for healthcare AI solutions.
While there was less money in early-stage financing and a surge in publicly-disclosed down rounds, investment in venture capital-backed healthcare companies ticked up in 2024, according t | Total investment in health tech companies grew by 17% in 2024. AI companies and women's health companies attracted investor interest.
Discover how the AI tool SearchGPT is revolutionising the pharma and healthcare industries, providing advanced search capabilities and insights for professionals in medical research and practice.
Improving health literacy is essential for patient understanding and better health outcomes. Learn three effective ways to enhance health literacy and empower patients.
ALG-801 could present new opportunities to improve treatment and management of patients with pulmonary arterial hypertension, a life-threatening condition.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
145 
Let's personalize your content